2. Search Result
Search Result
Results for "

127-69-5

" in MedChemExpress (MCE) Product Catalog:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-B0323
    Sulfisoxazole
    2 Publications Verification

    Sulfafurazole

    		 Endothelin Receptor Bacterial Antibiotic Infection Endocrinology Cancer
    Sulfisoxazole (Sulfafurazole) is an orally active endothelin receptor antagonist with IC50 values of 0.60 μM and 22 μM against endothelin receptor A and endothelin receptor B, respectively. Sulfisoxazole is a sulfonamide antibacterial agent with an oxazole substituent. Sulfisoxazole inhibits breast cancer exosome release by targeting endothelin receptor A .
    Sulfisoxazole
  • HY-B0323C
    Sulfisoxazole 100 µg/mL in methanol

    Sulfafurazole 100 µg/mL in methanol

    		 Others Infection
    Sulfisoxazole 100 μg/mL in methanol (Sulfafurazole 100 μg/mL in methanol) is a sulfonamide antimicrobial compound.
    Sulfisoxazole 100 µg/mL in methanol
  • HY-B0323R
    Sulfisoxazole (Standard)

    		Endothelin Receptor Bacterial Antibiotic Infection Endocrinology Cancer
    Sulfisoxazole (Standard) is the analytical standard of Sulfisoxazole. This product is intended for research and analytical applications. Sulfisoxazole (Sulfafurazole) is an orally active endothelin receptor antagonist with IC50 values of 0.60 μM and 22 μM against endothelin receptor A and endothelin receptor B, respectively. Sulfisoxazole is a sulfonamide antibacterial agent with an oxazole substituent. Sulfisoxazole inhibits breast cancer exosome release by targeting endothelin receptor A .
    Sulfisoxazole (Standard)
  • HY-B0323A
    Sulfisoxazole diethanolamine

    Sulfafurazole diethanolamine

    		 Endothelin Receptor Antibiotic Bacterial Infection Endocrinology Cancer
    Sulfisoxazole (Sulfafurazole) diethanolamine is an endothelin receptor antagonist with IC50 values of 0.60 μM and 22 μM against endothelin receptor A and endothelin receptor B, respectively. Sulfisoxazole diethanolamine is a sulfonamide antibacterial with an oxazole substituent. Sulfisoxazole diethanolamine inhibits breast cancer exosome release by targeting endothelin receptor A .
    Sulfisoxazole diethanolamine

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: